David W Gryska Seagen Inc. (SGEN) insider trading activity

David W Gryska is of Seagen Inc.. Currently has a direct ownership of 0 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2023, when has been sold 49,003 shares (Common Stock) at a price of $229.0 per share, resulting in proceeds of $11,221,687. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

DAVID W GRYSKA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 14 2023	SELL Sale (or disposition) back to the issuer	$11,221,687 $229.0 p/Share	49,003 Reduced 100.0%	0 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	2,044 Added 3.85%	51,047 Common Stock
Feb 13 2023	BUY Exercise of conversion of derivative security	$321,125 $36.7 p/Share	8,750 Added 15.15%	49,003 Common Stock
Nov 11 2022	SELL Open market or private sale	$968,250 $129.1 p/Share	7,500 Reduced 15.71%	40,253 Common Stock
May 13 2022	BUY Grant, award, or other acquisition	-	1,503 Added 3.05%	47,753 Common Stock
Apr 19 2022	SELL Open market or private sale	$576,760 $144.19 p/Share	4,000 Reduced 7.96%	46,250 Common Stock
Apr 19 2022	BUY Exercise of conversion of derivative security	$80,240 $20.06 p/Share	4,000 Added 7.85%	46,940 Common Stock
Feb 07 2022	SELL Open market or private sale	$623,295 $138.51 p/Share	4,500 Reduced 8.87%	46,250 Common Stock
Feb 07 2022	BUY Exercise of conversion of derivative security	$90,270 $20.06 p/Share	4,500 Added 8.47%	48,621 Common Stock
Jan 28 2022	SELL Open market or private sale	$553,230 $122.94 p/Share	4,500 Reduced 8.87%	46,250 Common Stock
Jan 28 2022	BUY Exercise of conversion of derivative security	$90,270 $20.06 p/Share	4,500 Added 8.83%	46,464 Common Stock
Jan 14 2022	SELL Open market or private sale	$608,580 $135.24 p/Share	4,500 Reduced 8.87%	46,250 Common Stock
Jan 14 2022	BUY Exercise of conversion of derivative security	$90,270 $20.06 p/Share	4,500 Added 8.14%	50,750 Common Stock
May 14 2021	BUY Grant, award, or other acquisition	-	1,402 Added 2.94%	46,250 Common Stock
Nov 19 2020	SELL Open market or private sale	$2,605,800 $173.72 p/Share	15,000 Reduced 25.06%	44,848 Common Stock
Nov 19 2020	BUY Exercise of conversion of derivative security	$285,300 $19.02 p/Share	15,000 Added 22.15%	52,719 Common Stock
Nov 05 2020	SELL Open market or private sale	$812,700 $180.6 p/Share	4,500 Reduced 9.12%	44,848 Common Stock

Also insider at

PDLI

PDL BIOPHARMA, INC.

Director

AERI

AERIE PHARMACEUTICALS INC Healthcare

Director

FBRX

Forte Biosciences, Inc. Healthcare

MNMD

Mind Medicine (MindMed) Inc. Healthcare

DWG

David W Gryska

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Seagen Inc.

Track Activities on SGEN

Account